Vir, GSK move Covid antibody drug into late-stage clinical trial,

GlaxoSmithKline plc will move an experimental monoclonal antibody treatment for Covid-19 into a late-stage, global clinical trial with some results expected as early as the end of this year. The move …, GlaxoSmithKline plc will move an experimental monoclonal antibody treatment for Covid-19 into a late-stage, global clinical trial with some results expected as early as the end of this year. The move …, Read More